Lack of reciprocity between opioid and 5-HT3 receptors for antinociception in rat spinal cord

Pharmacology

Volumn 77, Issue 4, 2006, Pages 195-202

  Myung, Ha Yoon ^a   Hong, Beom Bae ^a   Jeong, Il Choi ^a   Seok, Jai Kim ^a   Sung, Tae Chung ^a   Chang, Mo Kim ^a  

^a Chonnam National University   (South Korea)

Author keywords

5 HT3 receptor agonist, m CPBG; 5 HT3 receptor antagonists, LY 278,584, ondansetron; Antinociception; Formalin test; Opioid receptors; Reciprocity; Spinal cord

Indexed keywords

1 METHYL 3 INDAZOLECARBOXYLIC ACID N TROPANYLAMIDE; FORMALDEHYDE; MORPHINE; N (3 CHLOROPHENYL)IMIDODICARBONIMIDIC DIAMIDE HYDROCHLORIDE; NALOXONE; ONDANSETRON; OPIATE; OPIATE RECEPTOR; SEROTONIN 3 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; HINDLIMB; MALE; MOTOR PERFORMANCE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; VOMITING;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; BIGUANIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; HINDLIMB; INDAZOLES; INJECTIONS, SPINAL; MALE; MORPHINE; MOTOR ACTIVITY; MUSCLE TONUS; NALOXONE; NARCOTIC ANTAGONISTS; ONDANSETRON; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGONISTS; SPINAL CORD; TROPANES;

EID: 33748290099     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094763     Document Type: Article

References (29)

1. Goodchild CS, Nadeson R, Cohen E: Supraspinal and spinal cord opioid receptors are responsible for antinociception following intrathecal morphine injections. Eur J Anaesthesiol 2004;21:179-185.
2. Prado WA: Antinociceptive potency of intrathecal morphine in the rat tail flick test: a comparative study using acute lumbar catheter in rats with or without a chronic atlantooccipital catheter. J Neurosci Methods 2003;129:33-39.
3. Nishiyama T: Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test. Eur J Pharmacol 2000;395:203-210.
4. Zahn, PK, Gysbers D, Brennan TJ: Effect of systemic and intrathecal morphine in a rat model of postoperative pain. Anesthesiology 1997;86:1066-1077.
5. Miranda HF, Prieto JC, Pinardi G: Spinal synergy between nonselective cyclooxygenase inhibitors and morphine antinociception in mice. Brain Res 2005;1049:165-170.
6. 3 receptor antagonists. Oncology 1992;49:263-268.
7. Andrews PL, Davis CJ, Bingham S, Davidson HI, Hawthorn J, Maskell L: The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 1990;68:325-345.
8. 3 receptor in the rat central nervous system are mainly located on nerve fibers and terminals. Brain Res 1993;612:289-298.
9. Yazigi A, Chalhoub V, Madi-Jebara S, Fadia Haddad F, Hayek G: Prophylactic ondansetron is effective in the treatment of nausea and vomiting but not on pruritus after cesarean delivery with intrathecal sufentanilmorphine. J Clin Anesth 2002;14:183-186.
10. Kellstein DE, Malseed RT, Goldstein FJ: Opioid-monoamine interactions in spinal antinociception: evidence for serotonin but not norepinephrine reciprocity. Pain 1988;34:85-92.
11. Crisp T, Stafinsky JL, Uram M, Perni VC, Weaver MF, Spanos LJ: Serotonin contributes to the spinal antinociceptive effects of morphine. Pharmacol Biochem Behav 1991;39:591-595.
12. Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976;17:1031-1036.
13. Jeong CY, Choi JI, Yoon MH: Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 2004;502:205-211.
14. Yu SQ, Lundeberg T, Yu LC: Involvement of oxytocin in spinal antinociception in rats with inflammation. Brain Res 2003;983:13-22.
15. Yaksh TL: Preclinical models of nociception; in Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuyck JF, Saidman LJ (eds): Anesthesia: Biologic Foundations. Philadelphia, Lippincott-Raven, 1997, chap 40, pp 685-718.
16. 3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs 2005;19:225-338.
17. Furst S: Transmitters involved in antinociception in the spinal cord. Brain Res Bull 1999;48:129-141.
18. Barnes NM, Sharp T: A review of central 5-HT receptors and their function. Neuropharmacology 1999;38:1083-1152.
19. 3 receptor in the rat central nervous system are mainly located on nerve fibers and terminals. Brain Res 1993;612:289-298.
20. Fonseca MI, Ni YG, Dunning DD, Miledi R: Distribution of serotonin 2A, 2C and 3 receptor mRNA in spinal cord and medulla oblongata. Brain Res Mol Brain Res 2001;89:11-19.
21. Bardin L, Lavarenne J, Eschalier A: Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 2000;86:11-18.
22. 3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol 2001;424:45-52.
23. Fan P: Nonopioid mechanism of morphine modulation of the activation of 5-hydroxytryptamine type 3 receptors. Mol Pharmacol 1995;47:491-495.
24. Bell JA, Matsumiya T: Inhibitory effects of dorsal horn and excitant effects of ventral horn intraspinal microinjections of norepinephrine and serotonin in the cat. Life Sci 1981;29:1507-1514.
25. Yaksh TL, Wilson PR: Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther 1979;208:446-453.
26. Spanos LJ, Stafinsky JL, Crisp T: A comparative analysis of monoaminergic involvement in the spinal antinociceptive action of DAMPGO and DPDPE. Pain 1989;39:329-335.
27. Vasko MR, Pang IH, Vogt M: Involvement of 5-hydroxytryptamine-containing neurons in antinociception produced by injection of morphine into nucleus raphe magnus or onto spinal cord. Brain Res 1984;306:341-348.
28. 3 induced anti-nociception. Br J Pharmacol 1999;127:843-852.
29. Javanmardi K, Parviz M, Sadr SS, Keshavarz M, Minaii B, Dehpour AR: Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats. Clin Exp Pharmacol Physiol 2005;32:585-589.